Association of EMMPRIN and Fascin Expression in Renal Cell Carcinoma: Correlation with Clinicopathological Parameters

Overview

Journal World J Urol

Specialty Urology

Date 2006 Oct 6

PMID 17021824

Citations 18

Authors

Wen-Chiuan Tsai

Lai-Fa Sheu

Shin Nieh

Cheng-Ping Yu

Gung-Huan Sun

Yeh-Feng Lin

Ann Chen

Jong-Shiaw Jin

Affiliations

Soon will be listed here.

Abstract

EMMPRIN and fascin are important factors in tumor invasion and progression. We tested the hypothesis that expression of EMMPRIN and fascin correlate with clinicopathological parameters of renal cell carcinoma (RCC). Immunohistochemical analysis of EMMPRIN and fascin were performed in tissue microarrays of 100 surgical specimens, including 35 clear-cell RCC (CRCC), 21 clear-cell RCC with granular differentiation (GRCC), 12 chromophobe RCC (ChRCC), 8 papillary RCC (PRCC), 9 carcinoma of the collecting duct of Bellini (CDC), 10 clear-cell RCC with sarcomatoid differentiation (SRCC), and 6 metastatic RCC. Average immunoscores of EMMPRIN were 100.8 in CRCC, 195.2 in GRCC, 298.4 in ChRCC, 219.2 in PRCC, 186.1 in CDC, 226.9 in SRCC, and 151.7 in metastatic RCC. Among all included cases, average EMMPRIN immunoscores were 84.6 in grade I, 130.4 in grade II, 184.3 in grade III, and 223.5 in grade IV. Additionally, average immunostaining scores of fascin were 53.6 in CRCC, 289.3 in GRCC, 193.3 in ChRCC, 151.8 in PRCC, 181.3 in CDC, 275.4 in SRCC, and 131.7 in metastatic RCC. Average fascin immunoscores were 59.3 in grade I, 91.6 in grade II, 130.2 in grade III, and 194.7 in grade IV. Higher EMMPRIN and fascin immunoscores also correlated significantly with TNM stages and survival rates in RCC. Significant correlation was found between EMMPRIN and fascin expression. In conclusion, higher expression of EMMPRIN and fascin correlate significantly with histological grades, clinical stages, and survival rates of RCC.

Citing Articles

The Role of Fascin-1 in Human Urologic Cancers: A Promising Biomarker or Therapeutic Target?.

Zhang N, Bian Q, Gao Y, Wang Q, Shi Y, Li X Technol Cancer Res Treat. 2023; 22:15330338231175733.

PMID: 37246525 PMC: 10240877. DOI: 10.1177/15330338231175733.

FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance.

Li Z, Shi J, Zhang N, Zheng X, Jin Y, Wen S J Cancer. 2022; 13(8):2528-2539.

PMID: 35711849 PMC: 9174856. DOI: 10.7150/jca.67977.

Fascin actin-bundling protein 1 in human cancer: promising biomarker or therapeutic target?.

Liu H, Zhang Y, Li L, Cao J, Guo Y, Wu Y Mol Ther Oncolytics. 2021; 20:240-264.

PMID: 33614909 PMC: 7873579. DOI: 10.1016/j.omto.2020.12.014.

Characterization of CD147, CA9, and CD70 as Tumor-Specific Markers on Extracellular Vesicles in Clear Cell Renal Cell Carcinoma.

Himbert D, Zeuschner P, Ayoubian H, Heinzelmann J, Stockle M, Junker K Diagnostics (Basel). 2020; 10(12).

PMID: 33276608 PMC: 7761541. DOI: 10.3390/diagnostics10121034.

Fascin expression in urinary bladder urothelial carcinoma correlates with unfavourable prognosis.

Gomaa W, Al-Maghrabi H, Al-Attas M, Al-Ghamdi F, Al-Maghrabi J Int J Clin Exp Pathol. 2020; 12(10):3901-3907.

PMID: 31933780 PMC: 6949743.

References

Yang J, Xu Z, Wu H, Zhu H, Wu X, Hait W . Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol Cancer Res. 2003; 1(6):420-7. View

Roma A, Prayson R . Fascin expression in 90 patients with glioblastoma multiforme. Ann Diagn Pathol. 2005; 9(6):307-11. DOI: 10.1016/j.anndiagpath.2005.07.005. View

Hashimoto Y, Skacel M, Adams J . Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker?. Int J Biochem Cell Biol. 2005; 37(9):1787-804. DOI: 10.1016/j.biocel.2005.05.004. View

Grothey A, Hashizume R, Sahin A, McCrea P . Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br J Cancer. 2000; 83(7):870-3. PMC: 2374674. DOI: 10.1054/bjoc.2000.1395. View

Okada A, Bellocq J, Rouyer N, Chenard M, Rio M, Chambon P . Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci U S A. 1995; 92(7):2730-4. PMC: 42292. DOI: 10.1073/pnas.92.7.2730. View

Swierczynski S, Maitra A, Abraham S, Iacobuzio-Donahue C, Ashfaq R, Cameron J . Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Hum Pathol. 2004; 35(3):357-66. DOI: 10.1016/j.humpath.2003.10.012. View

Nabeshima K, Iwasaki H, Koga K, Hojo H, Suzumiya J, Kikuchi M . Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int. 2006; 56(7):359-67. DOI: 10.1111/j.1440-1827.2006.01972.x. View

Srigley J, HUTTER R, Gelb A, Henson D, Kenney G, King B . Current prognostic factors--renal cell carcinoma: Workgroup No. 4. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer. 1997; 80(5):994-6. DOI: 10.1002/(sici)1097-0142(19970901)80:5<994::aid-cncr27>3.0.co;2-q. View

Hashimoto Y, Shimada Y, Kawamura J, Yamasaki S, Imamura M . The prognostic relevance of fascin expression in human gastric carcinoma. Oncology. 2004; 67(3-4):262-70. DOI: 10.1159/000081327. View

10.

Duh F, Latif F, Weng Y, Geil L, Modi W, Stackhouse T . cDNA cloning and expression of the human homolog of the sea urchin fascin and Drosophila singed genes which encodes an actin-bundling protein. DNA Cell Biol. 1994; 13(8):821-7. DOI: 10.1089/dna.1994.13.821. View

11.

Guo H, Li R, Zucker S, Toole B . EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. Cancer Res. 2000; 60(4):888-91. View

12.

Adams J . Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol. 2004; 16(5):590-6. DOI: 10.1016/j.ceb.2004.07.009. View

13.

Ficarra V, Righetti R, Martignoni G, DAmico A, Pilloni S, Rubilotta E . Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases. Urol Int. 2001; 67(2):130-4. DOI: 10.1159/000050968. View

14.

Parkin D, Pisani P, Lopez A, Masuyer E . At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer. 1994; 59(4):494-504. DOI: 10.1002/ijc.2910590411. View

15.

Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H . The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res. 1995; 55(2):434-9. View

16.

Hu W, McCrea P, Deavers M, Kavanagh J, Kudelka A, Verschraegen C . Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors. Clin Exp Metastasis. 2001; 18(1):83-8. DOI: 10.1023/a:1026596609969. View

17.

Flanigan R . Debulking nephrectomy in metastatic renal cancer. Clin Cancer Res. 2004; 10(18 Pt 2):6335S-41S. DOI: 10.1158/1078-0432.CCR-sup-040026. View

18.

Chen C, Chen C, Wu M, Kuo T . Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer. 1992; 66(5):888-92. PMC: 1977977. DOI: 10.1038/bjc.1992.380. View

19.

Himelstein B, Bernhard E, Muschel R . Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J Cell Sci. 1994; 107 ( Pt 2):477-86. DOI: 10.1242/jcs.107.2.477. View

20.

Basset P, Bellocq J, Wolf C, Stoll I, Hutin P, Limacher J . A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature. 1990; 348(6303):699-704. DOI: 10.1038/348699a0. View